Luca Salerno

Rainbow Crops leverages multiplex genome editing, precision breeding, and AI to engineer crops with the genetic superpower to adapt to climate challenges, reduce chemical inputs, and enhance nutritional value. By targeting complex traits and improving multiple characteristics simultaneously, our technology tackles plant traits that have historically been difficult to enhance. We partner with seed companies and nonprofits to develop and make these advanced plant genetics accessible, benefiting farmers, consumers, and the environment, while driving sustainability and global food security.

Transformational protein technology for fat replacement, texture enhancement and nutrient delivery in the next generation of alt protein and reduced-fat foods.

X-Therma Inc. is solving unmet legacy needs in the storage of biological products using convergent biomimetic nanotechnology. This solution can better enable critical biomanufacture processes, safer transport and long-term biobanking for advanced cell therapies, in vitro fertilization, organ transplants, and other rapidly growing regenerative medicine areas.

Evergreen Theragnostics was established in 2019 to be a leading US-based radiopharmaceutical Contract Development and Manufacturing Organization (CDMO). Our team’s expertise and track record in theragnostic radiopharmaceutical commercialization, manufacturing process development, and regulatory affairs management, make us your ideal partner for all of your radiopharmaceutical development, manufacturing, and commercialization needs.

Chaired by the scientist and entrepreneur Stefano Buono, LIFTT came to life as an operating company in 2019 thanks to Compagnia di San Paolo, Politecnico di Torino and LINKS Foundation. The aim is to encourage technology development and transfer from University to Industry, but also to clear the way from a simple business idea to the creation of an innovative product, offering a dynamic and modern vision of venture capital as applied to Technology Transfer. LIFTT guarantees high visibility to ideas and new businesses at a national and international level, investing and attracting capital and ensuring maximum impact on the local and national territory. While generating value for its shareholders, LIFTT supports the creation of businesses, development, employment and economic growth, through the implementation of an ethical and transparent governance model, based on the participation of all the actors involved.

Our bite-sized crackers are really tasty and packed full with planet-positive protein, vitamin B12 and fibre. Ready to join this food revolution? If you like your snacks a little unusual, a lot sustainable and outrageously tasty, try Small Giants Crackers and change the word.

Rainbow Crops leverages multiplex genome editing, precision breeding, and AI to engineer crops with the genetic superpower to adapt to climate challenges, reduce chemical inputs, and enhance nutritional value. By targeting complex traits and improving multiple characteristics simultaneously, our technology tackles plant traits that have historically been difficult to enhance. We partner with seed companies and nonprofits to develop and make these advanced plant genetics accessible, benefiting farmers, consumers, and the environment, while driving sustainability and global food security.

Transformational protein technology for fat replacement, texture enhancement and nutrient delivery in the next generation of alt protein and reduced-fat foods.

X-Therma Inc. is solving unmet legacy needs in the storage of biological products using convergent biomimetic nanotechnology. This solution can better enable critical biomanufacture processes, safer transport and long-term biobanking for advanced cell therapies, in vitro fertilization, organ transplants, and other rapidly growing regenerative medicine areas.

Evergreen Theragnostics was established in 2019 to be a leading US-based radiopharmaceutical Contract Development and Manufacturing Organization (CDMO). Our team’s expertise and track record in theragnostic radiopharmaceutical commercialization, manufacturing process development, and regulatory affairs management, make us your ideal partner for all of your radiopharmaceutical development, manufacturing, and commercialization needs.

Chaired by the scientist and entrepreneur Stefano Buono, LIFTT came to life as an operating company in 2019 thanks to Compagnia di San Paolo, Politecnico di Torino and LINKS Foundation. The aim is to encourage technology development and transfer from University to Industry, but also to clear the way from a simple business idea to the creation of an innovative product, offering a dynamic and modern vision of venture capital as applied to Technology Transfer. LIFTT guarantees high visibility to ideas and new businesses at a national and international level, investing and attracting capital and ensuring maximum impact on the local and national territory. While generating value for its shareholders, LIFTT supports the creation of businesses, development, employment and economic growth, through the implementation of an ethical and transparent governance model, based on the participation of all the actors involved.